vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and Red Cat Holdings, Inc. (RCAT). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $9.6M, roughly 1.7× Red Cat Holdings, Inc.). CVRx, Inc. runs the higher net margin — -74.5% vs -166.0%, a 91.6% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs 4.4%). CVRx, Inc. produced more free cash flow last quarter ($-9.8M vs $-24.5M).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

CVRX vs RCAT — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.7× larger
CVRX
$16.0M
$9.6M
RCAT
Growing faster (revenue YoY)
RCAT
RCAT
+983.8% gap
RCAT
988.2%
4.4%
CVRX
Higher net margin
CVRX
CVRX
91.6% more per $
CVRX
-74.5%
-166.0%
RCAT
More free cash flow
CVRX
CVRX
$14.7M more FCF
CVRX
$-9.8M
$-24.5M
RCAT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CVRX
CVRX
RCAT
RCAT
Revenue
$16.0M
$9.6M
Net Profit
$-11.9M
$-16.0M
Gross Margin
86.3%
6.6%
Operating Margin
-69.8%
-181.7%
Net Margin
-74.5%
-166.0%
Revenue YoY
4.4%
988.2%
Net Profit YoY
-12.0%
-29.0%
EPS (diluted)
$-0.45
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
RCAT
RCAT
Q4 25
$16.0M
Q3 25
$14.7M
$9.6M
Q2 25
$13.6M
Q1 25
$12.3M
$1.6M
Q4 24
$15.3M
$0
Q3 24
$13.4M
Q2 24
$11.8M
Q1 24
$10.8M
$5.8M
Net Profit
CVRX
CVRX
RCAT
RCAT
Q4 25
$-11.9M
Q3 25
$-12.9M
$-16.0M
Q2 25
$-14.7M
Q1 25
$-13.8M
$-23.1M
Q4 24
$-10.7M
$-13.3M
Q3 24
$-13.1M
Q2 24
$-14.0M
Q1 24
$-22.2M
$-5.5M
Gross Margin
CVRX
CVRX
RCAT
RCAT
Q4 25
86.3%
Q3 25
86.8%
6.6%
Q2 25
84.3%
Q1 25
83.5%
-52.2%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
18.8%
Operating Margin
CVRX
CVRX
RCAT
RCAT
Q4 25
-69.8%
Q3 25
-83.5%
-181.7%
Q2 25
-105.8%
Q1 25
-108.8%
-765.7%
Q4 24
-67.0%
Q3 24
-97.3%
Q2 24
-118.3%
Q1 24
-206.4%
-76.0%
Net Margin
CVRX
CVRX
RCAT
RCAT
Q4 25
-74.5%
Q3 25
-87.6%
-166.0%
Q2 25
-108.4%
Q1 25
-111.5%
-1418.9%
Q4 24
-69.4%
Q3 24
-98.0%
Q2 24
-118.8%
Q1 24
-206.0%
-93.9%
EPS (diluted)
CVRX
CVRX
RCAT
RCAT
Q4 25
$-0.45
Q3 25
$-0.49
$-0.16
Q2 25
$-0.57
Q1 25
$-0.53
$-0.27
Q4 24
$-0.39
Q3 24
$-0.57
Q2 24
$-0.65
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
RCAT
RCAT
Cash + ST InvestmentsLiquidity on hand
$75.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$253.3M
Total Assets
$104.8M
$286.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
RCAT
RCAT
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Stockholders' Equity
CVRX
CVRX
RCAT
RCAT
Q4 25
$39.3M
Q3 25
$48.1M
$253.3M
Q2 25
$57.9M
Q1 25
$71.1M
$28.9M
Q4 24
$71.1M
$27.0M
Q3 24
$65.2M
Q2 24
$55.2M
Q1 24
$66.3M
$49.6M
Total Assets
CVRX
CVRX
RCAT
RCAT
Q4 25
$104.8M
Q3 25
$111.3M
$286.0M
Q2 25
$119.6M
Q1 25
$129.6M
$59.7M
Q4 24
$133.4M
$51.1M
Q3 24
$127.7M
Q2 24
$96.0M
Q1 24
$106.2M
$55.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
RCAT
RCAT
Operating Cash FlowLast quarter
$-9.8M
$-23.9M
Free Cash FlowOCF − Capex
$-9.8M
$-24.5M
FCF MarginFCF / Revenue
-61.3%
-254.2%
Capex IntensityCapex / Revenue
0.4%
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
RCAT
RCAT
Q4 25
$-9.8M
Q3 25
$-9.7M
$-23.9M
Q2 25
$-7.9M
Q1 25
$-12.8M
$-15.9M
Q4 24
$-8.0M
$-10.1M
Q3 24
$-10.4M
Q2 24
$-9.8M
Q1 24
$-10.9M
$-4.1M
Free Cash Flow
CVRX
CVRX
RCAT
RCAT
Q4 25
$-9.8M
Q3 25
$-10.0M
$-24.5M
Q2 25
$-8.0M
Q1 25
$-12.9M
$-16.2M
Q4 24
$-8.1M
$-10.2M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
$-4.2M
FCF Margin
CVRX
CVRX
RCAT
RCAT
Q4 25
-61.3%
Q3 25
-68.1%
-254.2%
Q2 25
-59.2%
Q1 25
-104.3%
-992.9%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
-71.1%
Capex Intensity
CVRX
CVRX
RCAT
RCAT
Q4 25
0.4%
Q3 25
2.0%
6.9%
Q2 25
0.8%
Q1 25
0.9%
16.8%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%
0.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

Related Comparisons